Tranexamic Acid for the Latarjet Procedure.

Sports Surgery Clinic, Santry, Dublin100 enrolled

Overview

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure. The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

100

Conditions

Anterior Shoulder Instability

Interventions

Tranexamic AcidDRUG

1g Tranexamic acid prior to skin incision

SalineDRUG

Equivalent volume of saline prior to skin incision

Eligibility

Sex: ALLMin age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: • Anterior shoulder instability, warranting the Latarjet procedure Exclusion Criteria: * Patients with known risk factors for hyper-coagulable state * Patients under 16 * Patients unable to give consent to partake in the trial

Locations (1)

Sports Surgery Clinic

Santry, Dublin, Ireland

Outcomes

Primary Outcomes

Hematoma Formation

Patients hematoma formation will be evaluated using the Pauzenberger criteria (Grade 1-4)

Time frame: Postoperative day-1

Visual Analogue Scale

Time frame: Postoperative day-1

Total Drain output

The total drain output of blood post-operatively

Time frame: Postoperative day-1

Opioid consumption

Time frame: Postoperative day-1

Secondary Outcomes

Wound complications

Time frame: Postoperative week-2

Total complications

Time frame: Postoperative month-4

Haematoma Formation

Time frame: Postoperative week-2

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.